1.08 USD
↘ 0.05 (4.42%)AT CLOSE (11:59 AM EDT)
60 Degrees Pharmaceuticals, Inc. Common Stock
SXTPNASDAQ • USD
1.06
↘ 0.02 (1.85%)
POST MARKET (AS OF 06:21 PM EDT)
Post Market
AS OF 06:21 PM EDT
1.06
↘ 0.02 (1.85%)
Market: CLOSED
Shares of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) are trading at $1.08. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 26, 2026.
Open?$1.12
High?$1.16
Low?$1.01
Prev. Close?$1.13
Volume?97.3K
Avg. Volume?93.8K
VWAP?$1.11
Rel. Volume?1.04x
Bid / Ask
Bid?$1.04 × 4.8K
Ask?$1.12 × 300
Spread?$0.08
Midpoint?$1.08
Valuation & Ratios
Market Cap?3.8M
Shares Out?3.5M
Float?2.6M
Float %?98.3%
P/E Ratio?N/A
P/B Ratio?1.45
EPS?-$2.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
Employees
3
Market Cap
4.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-07-12
Address
1025 CONNECTICUT AVENUE NW
WASHINGTON, DC 20036
Phone: 202-327-5422
WASHINGTON, DC 20036
Phone: 202-327-5422
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?50
Short Sent.?30
Piotroski F-Score?1/9Weak
Altman Z-Score?-21.53Distress
Confidence?58%Low
Short InterestHigh
Short % of Float?10.60%High
Short Interest?277.2K
Days to Cover?3.5
Free Float2.6M
Avg Daily Volume79.3K
Settlement Date2026-08-14
Financial Health
Current Ratio?2.32Strong
Quick Ratio?1.78Adequate
Cash Ratio?0.64Adequate
Debt/Equity?0.06Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?1.45CHEAP▾
Peers100
S&P88
P/S?3.13FAIR▾
Peers100
S&P49
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
S&P97
EV/Sales?2.41CHEAP▾
Peers100
S&P69
Returns & Efficiency
ROE?-329.6%WEAK▾
S&P3
ROA?-201.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-8894688
Enterprise Value?$2.9M
Fundamentals ratios updated end of day